Header image

ADS Clinical Orals 4: Dual GLP-1/GIP Agonists

Tracks
Stream 6
Thursday, August 24, 2023
4:00 PM - 6:00 PM
Hall B

Speaker

Dr Michael d'Emden
Senior Staff Specialist
Royal Brisbane and Women's Hospital

Changes in Liver and Abdominal Fat in Tirzepatide-Treated Patients Achieving Normoglycemia in the SURPASS-3 MRI Substudy

4:00 PM - 4:15 PM

Abstract

Biography

A/Prof d’Emden is the Director of Department of Endocrinology and Diabetes at the Royal Brisbane and Women’s Hospital. Michael was involved in the development of the Electronic Health Record used by Qld Health and the development of Australian Insulin In-patient management chart.
Prof Elif Ekinci
Dame Kate Campbell Fellow at The University of Melbourne
Australian Centre for Accelerating Diabetes Innovations (ACADI)

Tirzepatide Reduces Albuminuria in Patients with Type 2 Diabetes: Post-hoc Pooled Analysis of SURPASS 1-5

4:15 PM - 4:30 PM

Abstract

Biography

Professor Elif Ekinci is a clinician scientist and an academic endocrinologist. Her research is focused on the pathophysiology, prevention, detection and treatment of diabetes and its complications in humans. She collaborates with people to pave a path forward to translate discoveries into solutions that can change clinical practice.
Agenda Item Image
Prof Sarah Glastras
Endocrinologist
Royal North Shore Hospital

Tirzepatide reduces HbA1c and body weight significantly more than placebo or semaglutide irrespective of baseline beta-cell function: post-hoc analysis from SURPASS-1 and SURPASS-2

4:30 PM - 4:45 PM

Abstract

Biography

A/Prof Glastras is a clinician researcher; Senior Staff Specialist in Endocrinology at the Royal North Shore Hospital and Associate Professor at the Kolling Institute, University of Sydney. She currently holds the Australian Diabetes Society Skip Martin Fellowship undertaking prediction modelling of gestational diabetes and Training Lead of the TTRA-funded ACADI.
A/Prof Samantha Hocking
Associate Professor Diabetes NSW & ACT
Royal Prince Alfred Hospital / Central Clinical School / University of Sydney

The Effect of Tirzepatide During Weight Loss on Food Intake, Appetite, Food Preference and Food Craving in People with Obesity

4:45 PM - 5:00 PM

Abstract

Biography

Associate Professor Samantha Hocking is an Endocrinologist at Royal Prince Alfred Hospital and a Clinical Academic at the University of Sydney. She is the current President of the National Association of Clinical Obesity Services. Her research interests are focused on the metabolic complications of obesity.
Agenda Item Image
Dr Joey Kaye
Head of Department for Diabetes and Endocrinology
Sir Charles Gairdner Hospital

Longer Time Spent in Glycemic Control after Initiating Tirzepatide vs Comparators: Exploratory Analysis of SURPASS 1-5 Trial

5:00 PM - 5:15 PM

Abstract

Biography

Joey Kaye is a consultant endocrinologist and Head of Department, Diabetes and Endocrinology at Sir Charles Gairdner Hospital. He is a UWA Clinical Senior Lecturer and is Vice Chair of Diabetes Research WA. He completed his PhD in stress neuroendocrinology at the Henry Wellcome Laboratories for Integrative Neuroscience in Bristol, UK.
Agenda Item Image
Dr Ted Wu
Senior staff specialist
Royal Prince Alfred Hospital

Efficacy of Tirzepatide in People with Young-Onset T2D in the SURPASS Program

5:15 PM - 5:30 PM

Abstract

Biography

Dr Ted Wu is a senior staff specialist endocrinologist and the Director of the Diabetes Centre at The Royal Prince Alfred Hospital in Sydney, Australia, a visiting endocrinologist at Dubbo Base Hospital and an Honorary Professor at the Shijiazhuang Diabetes Hospital in Hebei, China.

Chairperson

Peter Shane Hamblin
Head of Endocrinology & Diabetes
Western Health

Mahesh Umapathysivam
Endocrinologist
Southern Adelaide Local Health Network / Central Adelaide Local Health Network

loading